Reply to Letter: "Adjuvant Antiviral Therapy With Nucleos(t)ide Analogs in Patients With Hepatitis B Virus--Related Hepatocellular Carcinoma"

Affiliations

¹ The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region.

Comment

Lei Yin et al. Ann Surg. 2017 Apr.

. 2017 Apr;265(4):e47-e48.

doi: 10.1097/SLA.0000000000001229.

¹ The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region.

No abstract available

Comment on

Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.
Huang G, Lau WY, Wang ZG, Pan ZY, Yuan SX, Shen F, Zhou WP, Wu MC. Huang G, et al. Ann Surg. 2015 Jan;261(1):56-66. doi: 10.1097/SLA.0000000000000858. Ann Surg. 2015. PMID: 25072444 Clinical Trial.
Postoperative Antiviral Therapy With Nucleos(t)ide Analogs in Patients With Hepatitis B Virus--Related Hepatocellular Carcinoma.
Zhong JH, Ma L, Li LQ. Zhong JH, et al. Ann Surg. 2017 Apr;265(4):e46-e47. doi: 10.1097/SLA.0000000000001224. Ann Surg. 2017. PMID: 28266988 No abstract available.